Cryoprotectant toxicity in Caenorhabditis elegans.

Area of Science:

• Cryobiology
• Toxicology
• Developmental Biology

Background:

• Cryoprotective agents are crucial for preserving biological samples and organs.
• M22 is a common vitrification solution used in organ transplantation.
• Understanding the toxicity of cryoprotectants in model organisms is essential for improving preservation techniques.

Purpose of the Study:

• To investigate the toxic effects of the cryoprotectant M22 on the survival and reproductive capacity of Caenorhabditis elegans.
• To identify genetic factors or pharmacological interventions that confer resistance to M22 toxicity.

Main Methods:

• Exposure of C. elegans wild-type and mutant strains to various concentrations of M22.
• Assessment of worm survival, progeny production, and developmental progression.
• Evaluation of the protective effect of afatinib against M22-induced toxicity.

Main Results:

• M22 exhibits concentration-dependent toxicity, reducing C. elegans survival and inhibiting development at concentrations of 10% (v/v) and above.
• Mutants in the insulin-like signaling (ILS) pathway demonstrate increased resistance to M22 toxicity compared to wild-type worms.
• Afatinib, an anti-cancer drug, effectively protects C. elegans against M22 toxicity without affecting lifespan.

Conclusions:

• M22 poses a significant toxicity risk to C. elegans, impacting survival and development.
• The insulin-like signaling pathway plays a role in M22 tolerance.
• Afatinib represents a potential therapeutic strategy to mitigate cryoprotectant toxicity in C. elegans.